feed,title,long_url,short_url
BioRxiv,A CNN model for predicting binding affinity changes between SARS-CoV-2 spike RBD variants and ACE2 homologues,https://biorxiv.org/cgi/content/short/2022.03.22.485413v1?rss=1,https://bit.ly/3wxA1H9
BioRxiv,"Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease",https://biorxiv.org/cgi/content/short/2022.03.23.485397v1?rss=1,https://bit.ly/3Ng83FB
BioRxiv,"Cellulosic copper nanoparticles and a hydrogen peroxide-based disinfectant protect Vero E6 cells against infection by viral pseudotyped particles expressing SARS-CoV-2, SARS-CoV or MERS-CoV Spike protein",https://biorxiv.org/cgi/content/short/2022.03.22.485373v1?rss=1,https://bit.ly/3IDs8Ci
BioRxiv,A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability,https://biorxiv.org/cgi/content/short/2022.03.22.485230v1?rss=1,https://bit.ly/3D4bDOu
BioRxiv,In silico analysis predicts a limited impact of SARS-CoV-2 variants on CD8 T cell recognition,https://biorxiv.org/cgi/content/short/2022.03.23.485487v1?rss=1,https://bit.ly/37J9xrJ
BioRxiv,Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2,https://biorxiv.org/cgi/content/short/2022.03.22.485418v1?rss=1,https://bit.ly/3wxgVRi
